Skip to content

Clinical trials

Phase 3 Breast Neoplasms trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 3 Country / region: Philippines Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20051
20064
20072
20082
20091
20103
20111
20121
20142
20162
20181
20192
20215
20221
20233
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting7
Recruiting4
Terminated4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Hoffmann-La Roche8
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals3
Genentech, Inc.2
International Breast Cancer Research Foundation2
Pfizer2
Tanvex BioPharma USA, Inc.2
Amgen1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms37
Neoplasm Metastasis7
Triple Negative Breast Neoplasms2
Anemia1
Bone Diseases, Metabolic1
Breast Diseases1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.